New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
07:50 EDTUTHR, UTHR, AVNR, AVNR, ALIOF, ALIOF, BMRN, BMRN, ACHN, ACHN, BIIB, BIIB, ICPT, ICPT, AEGR, AEGR, NPSP, NPSPDeutsche Bank to host a conference
BioFest is being held in Boston on December 2-3 with webcasted company presentations to begin on December 3 at 7:50 am; not all company presentations may be webcasted. Webcast Link
News For UTHR;AVNR;ALIOF;BMRN;ACHN;BIIB;ICPT;AEGR;NPSP From The Last 14 Days
Check below for free stories on UTHR;AVNR;ALIOF;BMRN;ACHN;BIIB;ICPT;AEGR;NPSP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2014
09:46 EDTBIIBBiogen hugs support at critical technical juncture, levels to watch
Subscribe for More Information
08:59 EDTICPTOn The Fly: Pre-market Movers
Subscribe for More Information
08:22 EDTBMRNBioMarin says FDA extends Kuvan market exclusivity by six months
Subscribe for More Information
07:33 EDTBIIBBiogen to present Plegridy, Tecfidera data at AAN annual meeting
Subscribe for More Information
April 12, 2014
20:04 EDTICPTIntercept reports additional positive data from POISE trial at EASL
Subscribe for More Information
April 11, 2014
10:15 EDTBIIBBiogen heads for test of $280 area
The shares are heading lower after an early bounce attempt and are now just above the session low at $280.13. As noted yesterday, a break below $280 would confirm topping in the shares. Support below $280 is at $273.45. Resistance is at $285.
09:08 EDTICPTIntercept announces OCA preclinical study data
Subscribe for More Information
April 10, 2014
15:13 EDTBIIBBiogen tumbles, nearing important test of support
Subscribe for More Information
09:00 EDTBIIBBiogen May volatility elevated at 43 into Q1 and revenue outlook
Subscribe for More Information
07:31 EDTBIIBBiogen names Adam Koppel as SVP, Chief Strategy Officer
Subscribe for More Information
07:24 EDTUTHR, ALIOFInternational Society for Heart & Lung Transplantation to hold annual meeting
Subscribe for More Information
07:08 EDTBIIBBiogen announces positive top-line efficacy, safety results from Phase 3 trial
Biogen Idec and Swedish Orphan Biovitrum AB released positive top-line results of the Kids A-LONG Phase 3 clinical study that evaluated the safety and efficacy of Eloctate, an investigational recombinant factor VIII Fc fusion protein product candidate, in children with severe haemophilia A. Eloctate was generally well-tolerated and no inhibitors were detected. Efficacy analyses showed twice-weekly prophylactic dosing with Eloctate maintained low bleeding rates in children.
April 9, 2014
08:08 EDTAEGRAegerion initiates Phase 3 clinical trial for lomitapide in Japan
Subscribe for More Information
07:23 EDTACHN, ICPTEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information
April 8, 2014
11:03 EDTICPT, AEGRPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
07:22 EDTUTHR, BIIBCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
April 7, 2014
11:17 EDTUTHRUnited Therapeutics upgraded to Buy from Hold at Standpoint Research
Subscribe for More Information
10:04 EDTBMRNBioMarin well positioned for revenue growth, says Summer Street
Subscribe for More Information
April 4, 2014
10:11 EDTICPTIntercept to present on POISE trial at EASL meeting
Subscribe for More Information
06:02 EDTICPTIntercept 1M share Secondary priced at $320.00
BofA/Merrill, Citigroup and Goldman acted as joint book running managers for the offering.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use